agilon health, inc.
AGL
$0.42
-$0.02-4.43%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.39% | -5.59% | -961.71% | 111.45% | 10.05% |
| Total Depreciation and Amortization | -190.59% | 1.52% | 6.44% | 271.64% | -164.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,071.85% | -189.09% | 174.63% | -222.42% | -13.91% |
| Change in Net Operating Assets | -10.85% | 75.36% | 236.30% | -136.68% | 14.79% |
| Cash from Operations | -13.13% | 48.26% | -9.69% | -294.82% | 313.15% |
| Capital Expenditure | 6.52% | 2.31% | 15.56% | -17.85% | 7.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.03% | -70.38% | 483.10% | -171.42% | -46.23% |
| Cash from Investing | 21.04% | -73.52% | 405.16% | -197.53% | -49.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 85.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.80% | 90.85% | -1,502.48% | -- | -- |
| Cash from Financing | 92.80% | 90.85% | -1,502.48% | -631.82% | 98.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 657.09% | -99.18% | 159.37% | -237.85% | 6.98% |